Owens & Minor Reports Consolidated Financial Results for 3rd Quarter 2012, Including Results from th
Owens & Minor Reports Consolidated Financial Results for 3rdQuarter 2012, Including Results from the Movianto Acquisition
- Owens & Minor to host Annual Investor Day on November 29, 2012 in New York
- Company completes acquisition of the Movianto Group, a leading European 3PL provider
RICHMOND, Va.--(BUSINESS WIRE)-- Owens & Minor, Inc. (NYSE-OMI)today reported financial results for the third quarter ended September 30, 2012, including consolidated quarterly revenue of $2.18 billion, unchanged when compared to revenue in the third quarter of 2011. The company's August 31, 2012, acquisition of the Movianto Group (Movianto) from Celesio AG contributed $49.7 million to revenue for the quarter, representing one month's revenue. Consolidated net income for the third quarter of 2012 was $24.6 million, or $0.39 per diluted share, compared to $33.4 million, or $0.53 per share, in the same period of 2011. Pre-tax costs associated with the Movianto acquisition were approximately $7.8 million for the third quarter of 2012, which reduced quarterly net income per diluted share by approximately $0.10.
"With the third party logistics capabilities of the Movianto acquisition and our core U.S. hospital distribution and supply chain services business, Owens & Minor now has global reach with a solid platform for providing third party logistics and other supply chain services," said Craig R. Smith, president & chief executive officer of Owens & Minor. "We believe this acquisition will improve the capacity of our company to serve healthcare providers and manufacturers with efficiency and innovation in a rapidly changing industry. We see emerging opportunity in healthcare and a widening path for Owens & Minor, as we position ourselves for the future."
Adjusted consolidated operating earnings for the third quarter of 2012, which exclude $7.8 million of costs associated with the Movianto acquisition, were $54.5 million, or 2.50% of revenues, a decrease of $4.3 million, when compared to $58.8 million, or 2.70% of revenues, in the prior-year third quarter. Included with the press release financial tables are reconciliations of the differences between the non-GAAP financial measures presented in this news release, which exclude acquisition-related expenses, and their most directly comparable GAAP financial measures.
For the nine months ended September 30, 2012, consolidated revenue was $6.58 billion, increased $151.2 million, or 2.4%, when compared to revenue of $6.43 billion for the same period of 2011. On a year-to-date basis, Movianto contributed revenues of $49.7 million. Consolidated net income for the first nine months of 2012 was $84.1 million, or $1.33 per diluted share, a decrease of $7.2 million when compared to net income of $91.3 million, or $1.44 per diluted share, for the same period of 2011. On a year-to-date basis, costs associated with the Movianto acquisition were approximately $8.4 million, which reduced net income by approximately $0.11 per diluted share.
For the first nine months of 2012, adjusted consolidated operating earnings, excluding Movianto acquisition-related costs, were $160.2 million, or 2.43% of revenues, essentially unchanged, when compared to operating earnings of $160.9 million, or 2.50% of revenues, for the same period last year.
"As we reflect on the third quarter 2012 results, we are targeting the fourth quarter 2012 adjusted operating results to be similar to those reported this quarter," said James L. Bierman, executive vice president & chief operating officer of Owens & Minor. "As our outlook further evolves, we will provide additional details at our annual Investor Day."
As a result of the August 31, 2012 acquisition of Movianto, Owens & Minor will now report Movianto as a separate International business segment. Prior to the acquisition, Owens & Minor had one reportable business segment, which now comprises the Domestic business segment. Accordingly, the Domestic business segment includes traditional distribution, OM HealthCare Logistics, and other supply-chain management services, such as OM SolutionsSM, which provide solutions to healthcare providers and suppliers of medical and surgical products in the United States. Additional information on segment results is provided in the accompanying financial tables.
In the third quarter of 2012, Domestic revenues were $2.13 billion, a decrease of $46.5 million compared to the same quarter of 2011. The decline resulted from a combination of factors, including: one less sales day in the quarter, lower comparative utilization of healthcare services coupled with reduced product price inflation, and a lower level of government purchasing, as well as ongoing rationalization of the company's supplier base.
Operating earnings for the Domestic segment for the third quarter of 2012 were $55.1 million compared to $58.8 million in the same period of 2011, a decrease of $3.7 million. The quarterly decrease in Domestic operating earnings is attributable to lower Domestic segment revenues and gross margin, partially offset by a $6.6 million improvement in SG&A expenses, when compared to the third quarter of 2011. As a percentage of revenues, Domestic operating earnings were 2.59% for the third quarter of 2012, representing a quarter-over-quarter decline of 11 basis points when compared to the same period of 2011, but also representing a 13 basis-point sequential improvement when compared to the second quarter of 2012.
Revenues in the International segment were $49.7 million for the third quarter of 2012, reflecting one month's contribution to the third quarter results, which were not included in results in the same quarter one year ago.
For the third quarter of 2012, the International segment had an operating loss of less than $1 million.
After completing the acquisition of Movianto, a leading European healthcare third-party logistics (3PL) business, Owens & Minor immediately launched the transition process. These activities include transitioning corporate functions previously handled by Movianto's parent company.
With the acquisition, Owens & Minor secured a third-party-logistics (3PL) platform that currently serves approximately 600 pharmaceutical and medical device manufacturer customers globally from 23 logistics centers in 11 European countries with approximately 1,800 teammates. Movianto provides a range of 3PL services including, warehousing, transportation, and cold chain logistics, as well as value-added services such as order-to-cash, repackaging and relabeling of products. Movianto's operational capabilities and services are highly complementary to those of OM HealthCare Logistics, Owens & Minor's domestic healthcare 3PL service, and the combination will enable Owens & Minor to offer healthcare manufacturers in the U.S. and Europe expanded global reach.
The balance of cash and cash equivalents at September 30, 2012, was $79.7 million, decreased from $135.9 million at December 31, 2011. The acquisition of Movianto used cash of approximately $150 million, net of cash acquired. Total interest-bearing debt as of September 30, 2012, was $217 million, compared to $215 million as of December 31, 2011. Domestic days sales outstanding (DSO) as of September 30, 2012, was 20.7, compared to DSO of 20.6 days at the end of the prior year's third quarter. Domestic inventory turns were 10.2 compared to turns of 10.3 for the same period last year.
Highlights & Upcoming Events
- The Owens & Minor board of directors declared a fourth quarter 2012 dividend of $0.22 per diluted share. The dividend is payable on December 31, 2012, to shareholders of record on December 14, 2012. Owens & Minor views dividends as an important component of total return to shareholders.
- Effective October 18, 2012, the Owens & Minor board of directors has named Martha Marsh, retired president & chief executive officer of Stanford Hospital and Clinics, to serve on the company's board of directors. Marsh brings more than 30 years of experience as a hospital executive to the Owens & Minor board.
- Owens & Minor is scheduled to participate in the 2012 Credit Suisse Healthcare Conference on November 15, 2012 in Phoenix. The presentation is scheduled for 11:00 a.m. Mountain Time.
- Owens & Minor has scheduled its Annual Investor Day in New York for Thursday, November 29, 2012. Owens & Minor executives will provide an operational and strategic overview, as well as the company's financial outlook for 2013. The meeting is scheduled to begin at 8:00 a.m. EST and conclude at approximately 10:30 a.m. EST. A live, listen-only webcast of the briefing can be accessed on the company website at www.owens-minor.com under the Investor Relations Section. Professional Wall Street analysts and investors may register via http://investors.owens-minor.com/registration.cfm.
Investors' 3Q 2012 Conference Call & Supplemental Material
Owens & Minor's management team will conduct a conference call to discuss the third quarter financial results on Tuesday, October 30, 2012, at 8:30 a.m. EDT. The access code for the conference call, international dial-in, and replay is #37884301. Participants may access the call at 866-393-1604. The international dial-in number is 224-357-2191. A replay of the call will be available for one week by dialing 855-859-2056. A webcast of the call, along with supplemental information, will be available on www.owens-minor.com under the Investor Relations section.
Owens & Minor uses its website, www.owens-minor.com, as a channel of distribution for material company information, including news releases, investor presentations and financial information. This information is routinely posted and accessible under the Investor Relations section.
Safe Harbor Statement
Except for historical information, the matters discussed in this press release may constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those projected. These risk factors are discussed in reports filed by the company with the Securities & Exchange Commission. All of this information is available at www.owens-minor.com. The company assumes no obligation, and expressly disclaims any such obligation, to update or alter information, whether as a result of new information, future events, or otherwise.
Owens & Minor, Inc., (NYS: OMI) a FORTUNE 500 company headquartered in Richmond, Virginia, is a leading national distributor of name-brand medical and surgical supplies and a healthcare supply-chain management company. Owens & Minor also offers global third-party logistics services to pharmaceutical and medical device manufacturers through its European business unit, Movianto, and through its U.S.-based service, OM HealthCare Logistics. Owens & Minor is also a member of the Russell 2000® Index, which measures the performance of the small-cap segment of the U.S. equity universe, as well as the S&P MidCap 400, which includes companies with a market capitalization of $1 billion to $4.4 billion that meet certain financial standards. With a diverse product and service offering and distribution centers throughout the United States, the company serves hospitals, integrated healthcare systems, alternate site locations, group purchasing organizations, healthcare suppliers and the federal government. Owens & Minor provides technology and consulting programs that improve inventory management and streamline logistics across the entire medical supply chain from origin of product to patient bedside. For news releases, or for more information about Owens & Minor, visit the company website at www.owens-minor.com.
|Owens & Minor, Inc.|
|Condensed Consolidated Statements of Income (unaudited)|
|(in thousands, except per share data)|
|Three Months Ended September 30,|
|Cost of goods sold||1,951,772||1,960,077|
|Selling, general and administrative expenses||165,320||152,825|
|Acquisition-related and exit and realignment charges||7,831||351|
|Depreciation and amortization||10,090||8,463|
|Other operating income, net||(1,781)||(3,422)|
|Interest expense, net||3,066||3,426|
|Income before income taxes||43,597||55,039|
|Income tax provision||19,000||21,687|
|Net income per common share:|
|Nine Months Ended September 30,|
|Cost of goods sold||5,929,341||5,788,499|
|Selling, general and administrative expenses||471,179||460,119|
|Acquisition-related and exit and realignment charges||8,448||351|
|Depreciation and amortization||27,184||25,479|
|Other operating income, net||(4,643)||(2,927)|
|Interest expense, net||9,975||10,163|
|Income before income taxes||141,737||150,338|
|Income tax provision||57,667||59,082|
|Net income per common share:|
|Owens & Minor, Inc.|
|Condensed Consolidated Balance Sheets (unaudited)|
|September 30,||December 31,|
|Cash and cash equivalents||$||79,667||$||135,938|
|Accounts and notes receivable, net||582,994||506,758|
|Other current assets||211,967||76,763|
|Total current assets||1,651,526||1,525,825|
|Property and equipment, net||176,035||108,061|
|Intangible assets, net||44,540||22,142|
|Other assets, net||64,285||42,289|
|Liabilities and equity|
|Accrued payroll and related liabilities||18,033||20,668|
|Deferred income taxes||36,982||42,296|
|Other current liabilities||252,131||93,608|
|Total current liabilities||949,269||732,365|
|Long-term debt, excluding current portion||214,795||212,681|
|Deferred income taxes||31,311||21,894|
|Total liabilities and equity||$||2,221,749||$||1,946,815|
|Owens & Minor, Inc.|
|Condensed Consolidated Statements of Cash Flows (unaudited)|
|Nine Months Ended September 30,|
|Adjustments to reconcile net income to cash provided by|
|operating activities of continuing operations:|
|Depreciation and amortization||27,184||25,479|
|Provision for LIFO reserve||5,223||11,265|
|Share-based compensation expense||4,844||4,335|
|Deferred income tax expense||1,098||908|
|Provision for losses on accounts and notes receivable||414||1,107|
|Changes in operating assets and liabilities:|
|Accounts and notes receivable||(7,886)||(36,598)|
|Net change in other assets and liabilities||(16,355)||(18,465)|
|Cash provided by operating activities of continuing operations||170,364||108,126|
|Acquisition, net of cash acquired||(149,910)||-|
|Additions to computer software and intangible assets||(19,934)||(8,035)|
|Additions to property and equipment||(7,890)||(16,846)|
|Proceeds from the sale of property and equipment||3,237||46|
|Cash used for investing activities of continuing operations||(174,497)||(24,835)|
|Cash dividends paid||(41,791)||(38,156)|
|Repurchases of common stock||(11,250)||(16,124)|
|Financing costs paid||(1,303)||-|
|Proceeds from termination of interest rate swap||-||4,005|
|Excess tax benefits related to share-based compensation||1,223||1,977|
|Proceeds from exercise of stock options||4,114||7,937|
|Cash used for financing activities of continuing operations||(53,451)||(45,488)|
|Operating cash flows||-||(164)|
|Net cash used for discontinued operations||-||(164)|
|Effect of exchange rate changes on cash and cash equivalents||1,313||-|
|Net (decrease) increase in cash and cash equivalents||(56,271)||37,639|
|Cash and cash equivalents at beginning of period||135,938||159,213|
|Cash and cash equivalents at end of period||$||79,667||$||196,852|